SCM
CDNA icon

Stonepine Capital Management’s CareDx CDNA Stock Holding History

Stonepine Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-920,000
Closed -$6.75M – 32
2017
Q4 		$6.75M Buy
+920,000
New +$5.74M 4.05% 11
2017
Q3 		– Sell
-190,909
Closed -$212K – 25
2017
Q2 		$212K Buy
+190,909
New +$203K 0.11% 26

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stonepine Capital Management's CDNA Position: Q1 2018 in Review

Stonepine Capital Management sold out of CareDx (CDNA) in Q1 2018, closing a stake of 920,000 shares — an estimated $6.75M sold.

Stonepine Capital Management first reported a position in CDNA in Q2 2017 and held it in 2 quarters. The position peaked at $6.75M in Q4 2017. 73 funds tracked by Wall St. Rank hold CDNA as of Q1 2018.

  • Stonepine Capital Management reported no remaining CareDx position as of Q1 2018 after selling out during the quarter.
  • Stonepine Capital Management sold 920,000 CareDx shares in Q1 2018, an estimated $6.75M.
  • Stonepine Capital Management first reported a position in CareDx in Q2 2017 and held it in 2 quarters.
  • Stonepine Capital Management's CareDx position peaked at $6.75M in Q4 2017.
  • 73 funds tracked by Wall St. Rank held CareDx as of Q1 2018.

Based on Stonepine Capital Management's 13F filing for Q1 2018, filed 14 May 2018.